Last reviewed · How we verify
NCT03486639
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
trial testing IPSS questionnaire in Overactive Bladder Syndrome in 330 participants. Status unknown.
1 April 2020
Quick facts
| Lead sponsor | Assaf-Harofeh Medical Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 330 |
| Start date | 1 July 2017 |
| Primary completion | 1 April 2020 |
| Estimated completion | 19 August 2020 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- IPSS questionnaire
Conditions studied
- Overactive Bladder Syndrome — all drugs for Overactive Bladder Syndrome →
- Bladder Outlet Obstruction — all drugs for Bladder Outlet Obstruction →
- Benign Prostate Enlargement — all drugs for Benign Prostate Enlargement →
- Stress Incontinence (Female) (Male) — all drugs for Stress Incontinence (Female) (Male) →
Sponsor
Assaf-Harofeh Medical Center
Who can join
18 and older, any sex, with Overactive Bladder Syndrome or Bladder Outlet Obstruction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Urodynamic examination evaluates storage and empting phases of the urinary bladder. It enables the clinician to correlate physiologic findings to patients' complains. The data gathered during the examination divided to storage and empting. During the storage phase, bladder sensation is measured while the bladder is filled with sterile water. During years of practice, we noticed that early sensation (bladder over-sensitivity) is occasionally associated with bladder outlet obstruction (as demonstrated in the emptying phase of the examination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Bladder Oversensitivity Is Associated with Bladder Outlet Obstruction in Men.
Verhovsky G, Baberashvili I, Rappaport YH, Zilberman DE, et al · · 2022 · cited 7× · PMID 36294814 · DOI 10.3390/jpm12101675
Verify or expand the search:
- PubMed search for NCT03486639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of IPSS questionnaire
Trials testing the same drug.
- NCT04446169 — COVID-19 (SARS-CoV-2) in Urine and Semen · completed
Other recruiting trials for Overactive Bladder Syndrome
Currently open trials in the same condition.
- NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
- NCT07081412 — Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation · NA · recruiting
- NCT07184307 — Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial · NA · recruiting
- NCT06546189 — Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial · NA · recruiting
- NCT06351683 — Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome · Phase 2 · recruiting
Other Assaf-Harofeh Medical Center trials
Trials by the same sponsor.
- NCT07334639 — Metabolic Changes Associated With Weight Gain After Treatment of Achalasia · not yet recruiting
- NCT07276334 — Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures · NA · enrolling by invitation
- NCT07231900 — Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients · Phase 2, PHASE3 · not yet recruiting
- NCT07252180 — Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA) · NA · active not recruiting
- NCT04664790 — Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03486639 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assaf-Harofeh Medical Center
- Last refreshed: 21 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03486639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing